Skip to main content
. 2021 Aug 13;8:691641. doi: 10.3389/fcvm.2021.691641

Table 2.

Lesion and treatment characteristics in the diabetes and the non-diabetes groups.

Variables Total population ( n = 719) P-value Propensity-matched patients ( n = 578) P-value
Diabetes (n = 316) Non-diabetes (n = 403) Diabetes (n = 289) Non-diabetes (n = 289)
Characteristics of CTO lesion
One CTO lesion 244 (77.2) 301 (74.7) 0.433 220 (76.1) 216 (74.7) 0.699
Two CTO lesions 41 (13.0) 68 (16.9) 0.148 39 (13.5) 48 (16.6) 0.295
Location of CTO lesions
LAD 131 (41.5) 163 (40.4) 0.785 116 (40.1) 118 (40.8) 0.865
LCX 57 (18.0) 57 (14.1) 0.156 54 (18.7) 41 (14.2) 0.145
RCA 132 (41.8) 186 (46.2) 0.240 123 (42.6) 133 (46.0) 0.402
Multivessel disease 267 (84.5) 331 (82.1) 0.401 245 (84.8) 236 (81.7) 0.316
Proximal or mid 240 (75.9) 324 (80.4) 0.150 219 (75.8) 233 (80.6) 0.158
Severe Calcification 20 (6.3) 23 (5.7) 0.727 19 (6.6) 22 (7.6) 0.627
Length ≥ 20 mm 283 (89.6) 373 (92.6) 0.158 258 (89.3) 268 (92.7) 0.146
Angulation > 45° 59 (18.7) 61 (15.1) 0.207 59 (20.4) 69 (23.9) 0.316
Vessel diameter (mm) 2.97 ± 0.5 2.99 ± 0.5 0.397 2.97 ± 0.5 2.99 ± 0.5 0.621
SYNTAX score 17.30 ± 9.0 17.30 ± 8.6 0.997 17.26 ± 9.1 17.17 ± 9.0 0.909
J-CTO score 1.17 ± 0.6 1.16 ± 0.5 0.877 1.16 ± 0.59 1.24 ± 0.57 0.100
Treatment characteristics
Number of stents for CTO-PCI
1 48 (15.2) 75 (18.6) 0.227 43 (14.9) 52 (18.0) 0.312
2 110 (34.9) 144 (35.7) 0.821 100 (34.6) 100 (34.6) 1.000
≥3 109 (34.5) 140 (34.7) 0.945 101 (34.9) 103 (35.6) 0.862
Stent length (mm) 53.42 ± 26.4 54.09 ± 25.5 0.742 52.98 ± 26.3 55.44 ± 26.4 0.283
IVUS use 38 (12.0) 52 (12.9) 0.724 35 (12.1) 38 (13.1) 0.707

Values are presented as mean ± standard deviation or number (%). CTO, chronic total occlusion; LAD, left ascending coronary artery; LCX, left circumflex coronary artery; RCA, right coronary artery; J-CTO, Japanese-chronic total occlusion; PCI, percutaneous coronary intervention; IVUS, intravenous ultrasound.